Longevity Acquisition (Longevity Acquisition) Risk Assessment

View and export this data going back to 2018. Start your Free Trial

What is Longevity Acquisition Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Longevity Acquisition is: No Data: Cannot be evaluated.

Competitive Comparison of Longevity Acquisition's Risk Assessment

For the Shell Companies subindustry, Longevity Acquisition's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longevity Acquisition's Risk Assessment Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Longevity Acquisition's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Longevity Acquisition's Risk Assessment falls into.

Longevity Acquisition (NAS:LOACU) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Longevity Acquisition Risk Assessment Related Terms

Thank you for viewing the detailed overview of Longevity Acquisition's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Acquisition (Longevity Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Longevity Acquisition Corp (NAS:LOACU) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

Longyang Road, Yongda International Tower No. 2277, Pudong District, Shanghai, CHN

Website

Longevity Acquisition Corp is a blank check company, formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities.

Executives

Glazer Capital, Llc	10 percent owner	250 WEST 55TH STREET, SUITE 30A, NEW YORK NY 10019
Paul J Glazer	10 percent owner	250 WEST 55TH ST, SUITE 30A, NEW YORK NY 10019
Yukman Lau	director	SUITE 807 CENTURY LINK PLAZA NO. 1196, CENTURY AVENUE, PUDONG DISTRICT F4 200000
Minguang Wang	director	YONGDA INTERNATIONAL TOWER NO. 2277, LONGEVITY ROAD, PUDONG DISTRICT, SHANGHAI F4 20000
Hudson Bay Capital Management Lp	10 percent owner	28 HAVEMEYER PLACE, 2ND FLOOR, GREENWICH CT 06830
Matthew Chen	director, 10 percent owner, officer: Chairman and CEO	YONGDA INTERNATIONAL TOWER 2277, LONGEVITY RD. PUDONG DISTRICT, SHANGHAI F4 20000
Sander Gerber	10 percent owner	C/O HUDSON BAY CAPITAL MANAGEMENT, L.P., 28 HAVEMEYER PLACE, 2ND FLOOR, GREENWICH CT 06830
Feng Peng	director	20 RIDGE ROAD, WARREN NJ 07059
Whale Management Corp	10 percent owner	YONGDA INTERNATIONAL TOWER NO. 2277, LONGEVITY RD. PUDONG DISTRICT, SHANGHAI F4 20000
Jun Liu	director	YONGDA INTERNATIONAL TOWER NO. 2277, LONGEVITY ROAD PUDONG DISTRICT, SHANGHAI F4 20000
Teddy Zheng	officer: CFO	YONGDA INTERNATIONAL TOWER NO. 2277, LONGEVITY ROAD, PUDONG DISTRICT, SHANGHAI F4 20000
Jason Zhang	director	YONGDA INTERNATIONAL TOWER NO. 2277, LONGEVITY ROAD, PUDONG DISTRICT, SHANGHAI F4 20000